4.6 Article

Kruppel-like factor 8 regulates triple negative breast cancer stem cell-like activity

Related references

Note: Only part of the references are listed.
Article Cell Biology

O-GlcNAcylation regulation of cellular signaling in cancer

Lorela Ciraku et al.

Summary: O-GlcNAcylation is a post-translational modification affecting protein stability, interactions, and phosphorylation, playing a crucial role in nutrient sensing and regulation of cancer signaling pathways. Its elevated levels have been linked to various cancers, making it a potential target for cancer treatment.

CELLULAR SIGNALLING (2022)

Article Dentistry, Oral Surgery & Medicine

KLF7 is associated with poor prognosis and regulates migration and adhesion in tongue cancer

Jiong Lyu et al.

Summary: The study found that KLF7 is overexpressed in TSCC and is significantly associated with T and N stages. Patients with high KLF7 expression have poorer overall survival. RNA sequencing and KEGG pathway analysis revealed that altered genes were enriched in extracellular matrix-receptor interactions and focal adhesions in both cell lines. KLF7 overexpression in TSCC cell lines enhanced migration capacity and cell adhesion, while knockdown of KLF7 expression reduced TSCC migration and adhesion abilities.

ORAL DISEASES (2022)

Article Multidisciplinary Sciences

Enhanced O-GlcNAc modification induced by the RAS/MAPK/CDK1 pathway is required for SOX2 protein expression and generation of cancer stem cells

Masahiro Shimizu et al.

Summary: Cancer stem cells (CSCs) have the ability to initiate and regenerate tumors. This study reveals that the oncogenic RAS gene can induce the expression of reprogramming factor SOX2, leading to the generation of CSCs. The activation of CDK1 and enhancement of protein O-GlcNAcylation are crucial for SOX2 induction and CSC generation.

SCIENTIFIC REPORTS (2022)

Article Oncology

Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel?

Xupeng Bai et al.

Summary: TNBC shows higher response rate to systemic therapy but poorer tumor differentiation, with higher tendency to metastasis and recurrence. Relapsed and metastatic TNBCs progress more rapidly, demonstrating strong resistance to chemotherapy and radiotherapy.

CANCER LETTERS (2021)

Review Chemistry, Multidisciplinary

Analytical and Biochemical Perspectives of Protein O-GlcNAcylation

Junfeng Ma et al.

Summary: Protein O-GlcNAcylation is an important post-translational modification that functions as a nutrient sensor and plays key roles in biochemical processes. Research on this modification has made significant progress in characterizing the components of O-GlcNAc cycling, biochemical properties of enzymes, and potential therapeutic applications. Challenges and solutions for future research in this field are also discussed.

CHEMICAL REVIEWS (2021)

Review Oncology

O-GlcNAc Transferase - An Auxiliary Factor or a Full-blown Oncogene?

Harri M. Itkonen et al.

Summary: OGT enzyme is involved in the posttranslational modification of serine and threonine residues, and its increased expression is a common feature in most human cancers. Inhibition of OGT reduces cancer cell proliferation by affecting known regulators of cancer cell proliferation. While OGT has potential in cancer therapy, further understanding of its substrate specificity and development of more specific inhibitors are needed.

MOLECULAR CANCER RESEARCH (2021)

Article Oncology

Exosomal O-GlcNAc transferase from esophageal carcinoma stem cell promotes cancer immunosuppression through up-regulation of PD-1 in CD8+ T cells

Yunfeng Yuan et al.

Summary: The study revealed that OGT in esophageal carcinoma stem cells can protect themselves from attacks by CD8(+) T cells by increasing the expression of PD-1 in CD8(+) T cells, which is of great significance for the treatment of esophageal cancer.

CANCER LETTERS (2021)

Article Oncology

Cancer statistics for the year 2020: An overview

Jacques Ferlay et al.

Summary: The study briefly reviews the methods and data sources used in compiling the IARC GLOBOCAN cancer statistics for 2020 and summarizes the main results. It estimated that there were nearly 19.3 million new cancer cases and almost 10 million cancer deaths worldwide in 2020, with the most commonly diagnosed cancers being female breast cancer and lung cancer, and the most common causes of cancer death being lung cancer and liver cancer.

INTERNATIONAL JOURNAL OF CANCER (2021)

Review Oncology

The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer

Lin He et al.

Summary: Triple negative breast cancer lacks targeted therapies and has poor prognosis. Chemotherapy is the main treatment, but recent advances have shown the importance of breast cancer stem cells in tumor initiation, metastasis, and chemoresistance. Targeting breast cancer stem cells may lead to new therapies that can improve patient survival rates.

CANCERS (2021)

Article Oncology

KLF5-induced lncRNA IGFL2-AS1 promotes basal-like breast cancer cell growth and survival by upregulating the expression of IGFL1

Haixia Wang et al.

Summary: This study elucidates the molecular mechanism by which KLF5 promotes the development of BLBC. IGFL2-AS1 is identified as a downstream target gene of KLF5, mediating the pro-proliferation and prosurvival functions of KLF5 by upregulating IGFL1's transcription. These findings suggest that IGFL2-AS1 and IGFL1 may serve as new therapeutic targets for BLBCs.

CANCER LETTERS (2021)

Article Biochemistry & Molecular Biology

Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer

Balazs Gyorffy

Summary: This study presents a ranking of all survival-related genes in chemotherapy treated basal and estrogen positive/HER2 negative breast cancer, providing a reference for future biomarker research. By analyzing hazard rates and p values of genes, the most promising prognostic genes can be identified, helping to focus research on candidates with the most clinical significance.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Article Oncology

O-GlcNAc Transferase Regulates Cancer Stem-like Potential of Breast Cancer Cells

Neha M. Akella et al.

MOLECULAR CANCER RESEARCH (2020)

Review Biochemistry & Molecular Biology

Targeting cancer stem cell pathways for cancer therapy

Liqun Yang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Endocrinology & Metabolism

O-GlcNAcylation Is Involved in the Regulation of Stem Cell Markers Expression in Colon Cancer Cells

Gabriela Fuentes-Garcia et al.

FRONTIERS IN ENDOCRINOLOGY (2019)

Review Cell & Tissue Engineering

Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment

Lan Thi Hanh Phi et al.

STEM CELLS INTERNATIONAL (2018)

Article Biochemistry & Molecular Biology

O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway

C. M. Ferrer et al.

ONCOGENE (2017)

Review Biochemistry & Molecular Biology

Cancer stem cells revisited

Eduard Batlle et al.

NATURE MEDICINE (2017)

Review Biochemistry & Molecular Biology

O-GIcNAcylation in Cancer Biology: Linking Metabolism and Signaling

Christina M. Ferrer et al.

JOURNAL OF MOLECULAR BIOLOGY (2016)

Article Oncology

mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer

Valerie L. Sodi et al.

MOLECULAR CANCER RESEARCH (2015)

Article Biochemistry & Molecular Biology

O-GlcNAcylation Regulates Cancer Metabolism and Survival Stress Signaling via Regulation of the HIF-1 Pathway

Christina M. Ferrer et al.

MOLECULAR CELL (2014)

Article Oncology

Biological subtypes of breast cancer: Prognostic and therapeutic implications

Ozlem Yersal et al.

WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)

Article Oncology

KLF8 involves in TGF-beta-induced EMT and promotes invasion and migration in gastric cancer cells

Hui Zhang et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)

Review Oncology

Mechanisms of chemoresistance in cancer stem cells

Lissa Nurrul Abdullah et al.

CLINICAL AND TRANSLATIONAL MEDICINE (2013)

Article Biochemistry & Molecular Biology

Sox2 expression in breast tumours and activation in breast cancer stem cells

O. Leis et al.

ONCOGENE (2012)

Review Medicine, General & Internal

Triple-Negative Breast Cancer

William D. Foulkes et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Cell Biology

A core Klf circuitry regulates self-renewal of embryonic stem cells

Jianming Jiang et al.

NATURE CELL BIOLOGY (2008)

Article Biochemistry & Molecular Biology

KLF8 transcription factor participates in oncogenic transformation

X. Wang et al.

ONCOGENE (2007)